Terns Pharmaceuticals Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Terns Pharmaceuticals stock had an average target of 45.22, with a low estimate of 7.44 and a high estimate of 54.

Price Target: $45.22 (-14.60%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.44	$45.22	$53	$54
Change	-85.95%	-14.60%	+0.09%	+1.98%

* Price targets were last updated on Apr 14, 2026.

Analyst Ratings

The average analyst rating for Terns Pharmaceuticals stock from 12 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	1	1
Buy	6	6	6	6	4	4
Hold	2	1	1	1	6	7
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	10	10	10	11	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jay Olson Oppenheimer	Oppenheimer	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Apr 27, 2026
Rodolfo Angele JP Morgan	JP Morgan	Buy Maintains $44 → $45	Buy	Maintains	$44 → $45	-15.96%	Apr 14, 2026
Srikripa Devarakonda Truist Securities	Truist Securities	Strong Buy → Hold Downgrades $56 → $53	Strong Buy → Hold	Downgrades	$56 → $53	+0.09%	Mar 31, 2026
Etzer Darout Barclays	Barclays	Buy → Hold Downgrades $56 → $53	Buy → Hold	Downgrades	$56 → $53	+0.09%	Mar 30, 2026
Silvan Tuerkcan Citizens	Citizens	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Mar 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.14

from -1.03

EPS Next Year

-1.45

from -1.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.00M	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-2.21	-1.67	-1.27	-1.12	-1.03	-1.14	-1.45
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.84	-1.03
Avg	-1.14	-1.45
Low	-1.45	-1.78

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.